| Immunometric assay interference: incidence and prevention J Bjerner, K Nustad, LF Norum, KH Olsen, OP Børmer Clinical chemistry 48 (4), 613-621, 2002 | 192 | 2002 |
| Human epididymis protein 4 reference limits and natural variation in a Nordic reference population N Bolstad, M Øijordsbakken, K Nustad, J Bjerner Tumor Biology 33, 141-148, 2012 | 175 | 2012 |
| Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors M Sprauten, M Brydøy, HS Haugnes, M Cvancarova, T Bjøro, J Bjerner, ... Journal of Clinical Oncology 32 (6), 571-578, 2014 | 110 | 2014 |
| The war on heterophilic antibody interference J Bjerner, OP Børmer, K Nustad Clinical chemistry 51 (1), 9-11, 2005 | 81 | 2005 |
| Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies DJ Warren, J Bjerner, E Paus, OP Børmer, K Nustad Clinical chemistry 51 (5), 830-838, 2005 | 69 | 2005 |
| Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors M Sprauten, HS Haugnes, M Brydøy, C Kiserud, T Tandstad, T Bjøro, ... Annals of Oncology 26 (10), 2133-2140, 2015 | 66 | 2015 |
| Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men N Reinton, H Moi, AO Olsen, N Zarabyan, J Bjerner, TM Tønseth, ... Sexual health 10 (3), 199-198, 2013 | 64 | 2013 |
| Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa‐foeto‐protein (AFP), neuron‐specific enolase (NSE) and CA19. 9 from the NORIP study J Bjerner, A Høgetveit, K Wold Akselberg, K Vangsnes, E Paus, T Bjøro, ... Scandinavian journal of clinical and laboratory investigation 68 (8), 703-713, 2008 | 64 | 2008 |
| Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera N Bolstad, DJ Warren, J Bjerner, G Kravdal, L Schwettmann, KH Olsen, ... Clinical Chemistry and Laboratory Medicine (CCLM) 49 (12), 2001-2006, 2011 | 58 | 2011 |
| Protein epitopes in carcinoembryonic antigen: Report of the ISOBM TD8 Workshop J Bjerner, Y Lebedin, L Bellanger, M Kuroki, JE Shively, T Varaas, ... Tumor biology 23 (4), 249-262, 2002 | 52 | 2002 |
| Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project J Bjerner, D Biernat, SD Fosså, T Bjøro Scandinavian journal of clinical and laboratory investigation 69 (8), 873-879, 2009 | 46 | 2009 |
| Human heterophilic antibodies display specificity for murine IgG subclasses J Bjerner, KH Olsen, OP Børmer, K Nustad Clinical biochemistry 38 (5), 465-472, 2005 | 40 | 2005 |
| Progastrin-releasing peptide: stability in plasma/serum and upper reference limit MS Nordlund, J Bjerner, DJ Warren, K Nustad, E Paus Tumor Biology 29 (3), 204-210, 2008 | 39 | 2008 |
| Automated time-resolved immunofluorometric assay for progastrin-releasing peptide MS Nordlund, DJ Warren, K Nustad, J Bjerner, E Paus Clinical chemistry 54 (5), 919-922, 2008 | 28 | 2008 |
| Human anti‐immunoglobulin antibodies interfering in immunometric assays J Bjerner Scandinavian journal of clinical and laboratory investigation 65 (5), 349-364, 2005 | 22 | 2005 |
| Serum levels of soluble transferrin receptor correlate with severity of disease but not with iron stores in patients with malignant lymphomas J Bjerner, LM Amlie, LS Rusten, E Jakobsen Tumor biology 23 (3), 146-153, 2002 | 19 | 2002 |
| MUC1 serum assays in breast cancer: tumor specificities and reference levels J Bjerner, LF Norum, O Nilsson, K Nustad Tumor biology 23 (6), 315-323, 2003 | 14 | 2003 |
| Rapid diagnosis and reduced workload for urinary tract infection using flowcytometry combined with direct antibiotic susceptibility testing HM Gilboe, OM Reiakvam, L Aasen, T Tjade, J Bjerner, TE Ranheim, ... PLoS One 16 (7), e0254064, 2021 | 13 | 2021 |
| Age‐dependent biochemical quantities: An approach for calculating reference intervals J Bjerner Scandinavian Journal of Clinical and Laboratory Investigation 67 (7), 707-722, 2007 | 12 | 2007 |
| Belief is only half the truth-or why screening for heterophilic antibody interference in certain assays makes double sense J Bjerner, N Bolstad, A Piehler Annals of Clinical Biochemistry 49 (4), 381-386, 2012 | 11 | 2012 |
Jan OldenburgUniversity of Oslo, Onc Dept, Akershus University Hospital在 medisin.uio.no 的电子邮件经过验证
